Drawing on the individual-specific functional network parcellation and machine learning approaches, the current study aimed at identifying the neuroimaging signatures in different APOE genotyping groups that could track cognitive symptoms from NA to AD. This evidence concerns the gene APOE and Alzheimer disease.